RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to
release third quarter 2017 financial and operating results after the
market closes on Thursday, November 9, 2017. Todd M. Pope, President and
Chief Executive Officer, and Joseph P. Slattery, Executive Vice
President and Chief Financial Officer will host a conference call to
discuss these results starting at 4:30 pm Eastern Time the same day. The
call will be concurrently webcast.
To listen to the conference call on your telephone, please dial (844)
804-5261 for domestic callers and (612) 979-9885 for international
callers, and reference conference ID 8898746 approximately ten minutes
prior to the start time. To access the live audio webcast or archived
recording, use the following link http://ir.transenterix.com/events.cfm.
The replay will be available on the Company's website.
TransEnterix is a medical device company that is pioneering the use of
robotics to improve minimally invasive surgery by addressing the
clinical and economic challenges associated with current laparoscopic
and robotic options. The Company is focused on the commercialization of
the Senhance™ Surgical Robotic System, a multi-port robotic system that
brings the advantages of robotic surgery to patients while enabling
surgeons with innovative technology such as haptic feedback and eye
sensing camera control. The Company also developed the SurgiBot™ System,
a single-port, robotically enhanced laparoscopic surgical platform. The
Senhance Surgical Robotic System has received FDA 510(k) clearance and
has been granted a CE Mark. For more information, visit the TransEnterix
website at www.transenterix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171023005662/en/
For TransEnterix, Inc.
Source: TransEnterix, Inc.
News Provided by Acquire Media